Isolated oligonucleotide and use thereof in nucleic acid sequencing
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/CN2014/086418, filed Sep 12, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,890,375 | Isolated oligonucleotide and use thereof in nucleic acid sequencing In force · High confidence | Mgi Tech Co., Ltd. | In force | High confidence | ||
| US 10,023,906 | Method for constructing nucleic acid single-stranded cyclic library and reagents thereof In force · High confidence | Mgi Tech Co., Ltd. | In force | High confidence | ||
| US 10,995,367 | Vesicular Adaptor and Uses Thereof in Nucleic Acid Library Construction and Sequencing In force · High confidence | Mgi Tech Co., Ltd. | In force | High confidence | ||
| US 10,544,451 | Vesicular linker and uses thereof in nucleic acid library construction and sequencing In force · High confidence | Mgi Tech Co., Ltd. | In force | High confidence |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.